Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas

Kazunori Shibao, Hiroshi Takano, Yoshifumi Nakayama, Keisuke Okazaki, Naoki Nagata, Hiroto Izumi, Takeshi Uchiumi, Michihiko Kuwano, Kimitoshi Kohno, Hideaki Itoh

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

The transcription factor YB-1 is expressed in a wide range of cell types and has been implicated in the regulation of various genes involved in cell proliferation. Nuclear expression of YB-1 is correlated with MDR-1 gene expression in breast cancer and osteosarcoma. In this study, we asked whether YB-1 expression is enhanced in human colorectral carcinoma and if it is associated with the expression of target genes such as MDR-1, DNA topoisomerase II α and PCNA. YB-1, DNA topoisomerase II α, PCNA and MDR-1 expression were assessed by Western blotting, Northern blotting and immunohistochemistry in 26 human colorectal carcinomas. The involvement of YB-1 in DNA topoisomerase II α gene expression was examined by transient DNA transfection assays. YB-1 was overexpressed in almost all cancerous lesions in comparison with normal mucosa in surgically resected colorectal carcinomas of 26 patients. YB-1 expression correlated well with both DNA topoisomerase II α and PCNA expression. In contrast, no correlation was observed between YB-1 and MDR-1 expression. We also found that a transient co-transfection with a DNA topoisomerase II promoter-luciferase plasmid and an antisense YB-1 expression construct resulted in a significant reduction of the promoter activity in KM12C human colon cancer cells. YB-1 may be an excellent proliferation-associated marker and may be a transcription factor regulating DNA topoisomerase II gene expression in human colorectal carcinoma.

Original languageEnglish
Pages (from-to)732-737
Number of pages6
JournalInternational Journal of Cancer
Volume83
Issue number6
DOIs
Publication statusPublished - Jan 1 1999

Fingerprint

Type II DNA Topoisomerase
Colorectal Neoplasms
Proliferating Cell Nuclear Antigen
Genes
Gene Expression
Transfection
Transcription Factors
MDR Genes
Osteosarcoma
Luciferases
Northern Blotting
Colonic Neoplasms
Mucous Membrane
Plasmids
Western Blotting
Immunohistochemistry
Cell Proliferation
Breast Neoplasms
Carcinoma
DNA

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas. / Shibao, Kazunori; Takano, Hiroshi; Nakayama, Yoshifumi; Okazaki, Keisuke; Nagata, Naoki; Izumi, Hiroto; Uchiumi, Takeshi; Kuwano, Michihiko; Kohno, Kimitoshi; Itoh, Hideaki.

In: International Journal of Cancer, Vol. 83, No. 6, 01.01.1999, p. 732-737.

Research output: Contribution to journalArticle

Shibao, Kazunori ; Takano, Hiroshi ; Nakayama, Yoshifumi ; Okazaki, Keisuke ; Nagata, Naoki ; Izumi, Hiroto ; Uchiumi, Takeshi ; Kuwano, Michihiko ; Kohno, Kimitoshi ; Itoh, Hideaki. / Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas. In: International Journal of Cancer. 1999 ; Vol. 83, No. 6. pp. 732-737.
@article{dce53a7f382040d0a856ca5988d60428,
title = "Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas",
abstract = "The transcription factor YB-1 is expressed in a wide range of cell types and has been implicated in the regulation of various genes involved in cell proliferation. Nuclear expression of YB-1 is correlated with MDR-1 gene expression in breast cancer and osteosarcoma. In this study, we asked whether YB-1 expression is enhanced in human colorectral carcinoma and if it is associated with the expression of target genes such as MDR-1, DNA topoisomerase II α and PCNA. YB-1, DNA topoisomerase II α, PCNA and MDR-1 expression were assessed by Western blotting, Northern blotting and immunohistochemistry in 26 human colorectal carcinomas. The involvement of YB-1 in DNA topoisomerase II α gene expression was examined by transient DNA transfection assays. YB-1 was overexpressed in almost all cancerous lesions in comparison with normal mucosa in surgically resected colorectal carcinomas of 26 patients. YB-1 expression correlated well with both DNA topoisomerase II α and PCNA expression. In contrast, no correlation was observed between YB-1 and MDR-1 expression. We also found that a transient co-transfection with a DNA topoisomerase II promoter-luciferase plasmid and an antisense YB-1 expression construct resulted in a significant reduction of the promoter activity in KM12C human colon cancer cells. YB-1 may be an excellent proliferation-associated marker and may be a transcription factor regulating DNA topoisomerase II gene expression in human colorectal carcinoma.",
author = "Kazunori Shibao and Hiroshi Takano and Yoshifumi Nakayama and Keisuke Okazaki and Naoki Nagata and Hiroto Izumi and Takeshi Uchiumi and Michihiko Kuwano and Kimitoshi Kohno and Hideaki Itoh",
year = "1999",
month = "1",
day = "1",
doi = "10.1002/(sici)1097-0215(19991210)83:6<732::aid-ijc6>3.0.co;2-{\%}23",
language = "English",
volume = "83",
pages = "732--737",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas

AU - Shibao, Kazunori

AU - Takano, Hiroshi

AU - Nakayama, Yoshifumi

AU - Okazaki, Keisuke

AU - Nagata, Naoki

AU - Izumi, Hiroto

AU - Uchiumi, Takeshi

AU - Kuwano, Michihiko

AU - Kohno, Kimitoshi

AU - Itoh, Hideaki

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The transcription factor YB-1 is expressed in a wide range of cell types and has been implicated in the regulation of various genes involved in cell proliferation. Nuclear expression of YB-1 is correlated with MDR-1 gene expression in breast cancer and osteosarcoma. In this study, we asked whether YB-1 expression is enhanced in human colorectral carcinoma and if it is associated with the expression of target genes such as MDR-1, DNA topoisomerase II α and PCNA. YB-1, DNA topoisomerase II α, PCNA and MDR-1 expression were assessed by Western blotting, Northern blotting and immunohistochemistry in 26 human colorectal carcinomas. The involvement of YB-1 in DNA topoisomerase II α gene expression was examined by transient DNA transfection assays. YB-1 was overexpressed in almost all cancerous lesions in comparison with normal mucosa in surgically resected colorectal carcinomas of 26 patients. YB-1 expression correlated well with both DNA topoisomerase II α and PCNA expression. In contrast, no correlation was observed between YB-1 and MDR-1 expression. We also found that a transient co-transfection with a DNA topoisomerase II promoter-luciferase plasmid and an antisense YB-1 expression construct resulted in a significant reduction of the promoter activity in KM12C human colon cancer cells. YB-1 may be an excellent proliferation-associated marker and may be a transcription factor regulating DNA topoisomerase II gene expression in human colorectal carcinoma.

AB - The transcription factor YB-1 is expressed in a wide range of cell types and has been implicated in the regulation of various genes involved in cell proliferation. Nuclear expression of YB-1 is correlated with MDR-1 gene expression in breast cancer and osteosarcoma. In this study, we asked whether YB-1 expression is enhanced in human colorectral carcinoma and if it is associated with the expression of target genes such as MDR-1, DNA topoisomerase II α and PCNA. YB-1, DNA topoisomerase II α, PCNA and MDR-1 expression were assessed by Western blotting, Northern blotting and immunohistochemistry in 26 human colorectal carcinomas. The involvement of YB-1 in DNA topoisomerase II α gene expression was examined by transient DNA transfection assays. YB-1 was overexpressed in almost all cancerous lesions in comparison with normal mucosa in surgically resected colorectal carcinomas of 26 patients. YB-1 expression correlated well with both DNA topoisomerase II α and PCNA expression. In contrast, no correlation was observed between YB-1 and MDR-1 expression. We also found that a transient co-transfection with a DNA topoisomerase II promoter-luciferase plasmid and an antisense YB-1 expression construct resulted in a significant reduction of the promoter activity in KM12C human colon cancer cells. YB-1 may be an excellent proliferation-associated marker and may be a transcription factor regulating DNA topoisomerase II gene expression in human colorectal carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0032707960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032707960&partnerID=8YFLogxK

U2 - 10.1002/(sici)1097-0215(19991210)83:6<732::aid-ijc6>3.0.co;2-%23

DO - 10.1002/(sici)1097-0215(19991210)83:6<732::aid-ijc6>3.0.co;2-%23

M3 - Article

C2 - 10597187

AN - SCOPUS:0032707960

VL - 83

SP - 732

EP - 737

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -